4.7 Letter

Cochlear transduction via cerebrospinal fluid delivery of AAV in non-human primates

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate

Eva Andres-Mateos et al.

Summary: The study demonstrates the feasibility and efficiency of using AAV vectors, specifically Anc80L65, for gene therapy in nonhuman primate models of hearing and balance disorders. The results suggest that Anc80L65 achieves higher levels of cochlear gene transfer compared to AAV1, motivating further studies in human patients.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing

Trevor J. Gonzalez et al.

Summary: Researchers have successfully generated a cross-species compatible AAV (ccAAVs) vector using a viral evolutionary approach, and discovered a highly potent new variant AAV.cc47. AAV.cc47 demonstrated enhanced transduction efficiency compared to AAV serotype 9 in mouse, pig, and non-human primate models, showing great potential for gene therapy. This study focuses on investigating cross-species delivery of AAV and provides new theoretical insights for translating gene therapy into clinical applications.

NATURE COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid

David Goertsen et al.

Summary: Advances in AAV engineering have provided new tools for research and gene therapy. This study engineering the AAV9 capsid protein to target the lung in mice, resulting in improved transgene expression, including in alveolar epithelial type II cells.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)

Article Biotechnology & Applied Microbiology

The clinical landscape for AAV gene therapies

Dmitry A. Kuzmin et al.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Biochemistry & Molecular Biology

Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain

Megan S. Keiser et al.

Summary: The preclinical safety study of RNA interference (RNAi) for spinocerebellar ataxia type 1 therapy showed toxicity in nonhuman primates but not in rodents, due to unexpected AAV inverted terminal repeat transcriptional activity that was mitigated by altering the RNAi expression environment.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism

Marcus Davidsson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Neurosciences

Rhesus Cochlear and Vestibular Functions Are Preserved After Inner Ear Injection of Saline Volume Sufficient for Gene Therapy Delivery

Chenkai Dai et al.

JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY (2017)

Article Multidisciplinary Sciences

Intravenous rAAV2/9 injection for murine cochlear gene delivery

Seiji B. Shibata et al.

SCIENTIFIC REPORTS (2017)

Article Medicine, Research & Experimental

Cochlear gene transfer mediated by adeno-associated virus: Comparison of two surgical approaches

Wade W. Chien et al.

LARYNGOSCOPE (2015)

Article Biochemistry & Molecular Biology

Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear

L. A. Kilpatrick et al.

GENE THERAPY (2011)

Article Biotechnology & Applied Microbiology

The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice

K Kawamoto et al.

MOLECULAR THERAPY (2001)

Article Biochemistry & Molecular Biology

A specific promoter of the sensory cells of the inner ear defined by transgenesis

B Boëda et al.

HUMAN MOLECULAR GENETICS (2001)

Article Biochemistry & Molecular Biology

Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer

T Stover et al.

GENE THERAPY (2000)